Inventor
TU YONG
US17 patents
⚠️ This page may combine multiple inventors who share the name “TU YONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
12 patentsUS6878722B2Apr 12, 2005
Substituted cycloalkyl P1′ hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO134 citations97
US7473688B2Jan 6, 2009
Indolobenzazepine HCV NS5B inhibitors
BRISTOL MYERS SQUIBB CO26 citations92
US7309708B2Dec 18, 2007
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO39 citations92
US7547690B2Jun 16, 2009
Compounds for the treatment of Hepatitis C
BRISTOL MYERS SQUIBB CO8 citations84
US7541353B2Jun 2, 2009
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO11 citations84
US7538103B2May 26, 2009
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO17 citations84
US7538102B2May 26, 2009
Compounds for the treatment of Hepatitis C
BRISTOL MYERS SQUIBB CO16 citations84
US7521444B2Apr 21, 2009
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO17 citations84
US9326973B2May 3, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO12 citations79
US9717712B2Aug 1, 2017
Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus
BRISTOL MYERS SQUIBB CO1 citations52
US10617675B2Apr 14, 2020
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations50
US9770439B2Sep 26, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations37
VIIV HEALTHCARE UK NO 5 LTD
2 patentsUS10351546B2Jul 16, 2019
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD1 citations62
US10106504B2Oct 23, 2018
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD0 citations41